Meditera Tibbi Malzeme Sanayi ve Ticaret AS - Asset Resilience Ratio
Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) has an Asset Resilience Ratio of 1.26% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Meditera Tibbi Malzeme Sanayi ve Ticaret (MEDTR) strategic asset index to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2025)
This chart shows how Meditera Tibbi Malzeme Sanayi ve Ticaret AS's Asset Resilience Ratio has changed over time. See MEDTR equity to assets ratio to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Meditera Tibbi Malzeme Sanayi ve Ticaret AS's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Meditera Tibbi Malzeme Sanayi ve Ticaret (MEDTR) total market value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | TL0.00 | 0% |
| Short-term Investments | TL48.02 Million | 1.26% |
| Total Liquid Assets | TL48.02 Million | 1.26% |
Asset Resilience Insights
- Limited Liquidity: Meditera Tibbi Malzeme Sanayi ve Ticaret AS maintains only 1.26% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Meditera Tibbi Malzeme Sanayi ve Ticaret AS Industry Peers by Asset Resilience Ratio
Compare Meditera Tibbi Malzeme Sanayi ve Ticaret AS's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351 |
Medical Devices | 49.23% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 5.73% |
|
Shenzhen Lifotronic Technology Co
SHG:688389 |
Medical Devices | 2.53% |
|
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186 |
Medical Devices | 0.84% |
|
Eurobio Scientific SA
PA:ALERS |
Medical Devices | 10.52% |
Annual Asset Resilience Ratio for Meditera Tibbi Malzeme Sanayi ve Ticaret AS (2021–2025)
The table below shows the annual Asset Resilience Ratio data for Meditera Tibbi Malzeme Sanayi ve Ticaret AS.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 1.96% | TL70.46 Million ≈ $1.58 Million |
TL3.59 Billion ≈ $80.42 Million |
-2.73pp |
| 2024-12-31 | 4.69% | TL172.55 Million ≈ $3.86 Million |
TL3.68 Billion ≈ $82.38 Million |
-9.84pp |
| 2023-12-31 | 14.53% | TL397.22 Million ≈ $8.90 Million |
TL2.73 Billion ≈ $61.21 Million |
-9.67pp |
| 2022-12-31 | 24.20% | TL266.08 Million ≈ $5.96 Million |
TL1.10 Billion ≈ $24.63 Million |
+5.67pp |
| 2021-12-31 | 18.53% | TL133.29 Million ≈ $2.99 Million |
TL719.21 Million ≈ $16.11 Million |
-- |
About Meditera Tibbi Malzeme Sanayi ve Ticaret AS
Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi manufactures and sells medical devices in Turkey. The company offers two-way and single-line Infusion Systems; Chemotherapy Preparation and Administration Systems, such as medoconco automated drug preparation, diana semi-automatic drug dispensing, and ICU medical chemotherapy drug delivery systems; and respiratory systems products, includin… Read more